1. SLAM Family Receptors in B Cell Chronic Lymphoproliferative Disorders.
- Author
-
Kľoc, Dominik, Kurhajec, Slavomír, Huniadi, Mykhailo, Sýkora, Ján, Guman, Tomáš, and Šarišský, Marek
- Subjects
CELL receptors ,LYMPHOPROLIFERATIVE disorders ,T cells ,KILLER cells ,B cells ,PROGENITOR cells ,B cell receptors - Abstract
The signaling lymphocytic activation molecule (SLAM) receptor family (SLAMF) consists of nine glycoproteins that belong to the CD2 superfamily of immunoglobulin (Ig) domain-containing molecules. SLAMF receptors modulate the differentiation and activation of a wide range of immune cells. Individual SLAMF receptors are expressed on the surface of hematopoietic stem cells, hematopoietic progenitor cells, B cells, T cells, NK cells, NKT cells, monocytes, macrophages, dendritic cells, neutrophils, and platelets. The expression of SLAMF receptors was studied during normal B cell maturation. Several SLAMF receptors were also detected in cancer cell lines of B-lymphoid origin and in pathological B cells from patients with B cell chronic lymphoproliferative disorders (B-CLPD), the most frequent hematological malignancies in adults. This review summarizes current knowledge on the expression of SLAMF receptors and their adaptor proteins SAP and EAT-2 in B-CLPD. Several SLAMF receptors could be regarded as potential diagnostic and differential diagnostic markers, prognostic factors, and targets for the development of novel drugs for patients with B-CLPD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF